COVID-19 STAndard of Care in Sub-Saharan Africa

Observational Study of the Clinico-biological Evolution and the Standard of Care Offered to Symptomatic Covid-19 Patients in Sub-Saharan Africa

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04885543

Acronym

COVISTA

Enrollment

2495

Registered

2021-05-13

Start date

2020-03-01

Completion date

2021-03-01

Last updated

2021-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

This study was conducted in three African countries on four COVID-19 care centers (CCCs). The CCCs were set up in collaboration with a medical NGO with long experience in recording and monitoring data for cohorts and clinical trials in emergency contexts. The data were recorded using the WHO COVID-19 rapid core case report form.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* SARS-CoV-2 positive at RT-PCR

Exclusion criteria

* Asymptomatic patients

Design outcomes

Primary

Measure	Time frame	Description
Mortality	During hospitalization, with an average of 11 days	In hospital mortality

Secondary

Measure	Time frame	Description
Clinical worsening	Hospitalization, with an average of 11 days	Combination of an SpO2 \<94% at least once during follow-up (including at baseline), use of oxygen therapy at any time during follow-up, or death

Countries

Burkina Faso, Guinea

Outcome results